格式塔科技完成1.5亿元天使轮融资，国内脑机接口领域最大规模天使轮

Core Viewpoint - Gestala Technology, the first domestic company focused on ultrasound brain-machine interfaces, has completed a 150 million yuan angel round financing, setting a record for the highest angel round financing in China's brain-machine interface sector [4][5]. Financing Details - The financing round was led by Guosheng Capital and Daotong Investment, with participation from several well-known investment institutions and companies, including Qingsong Capital and Gobi Partners [4]. - The funds raised will primarily be invested in product development and early clinical trials, focusing on core technology, clinical registration, AI integration, and advanced technology layout [6][7]. Industry Context - The global brain-machine interface industry is experiencing an investment boom, particularly in the "ultrasound track," with notable companies like Merge Labs and Nudge also securing significant funding [5]. - The advantages of ultrasound pathways over traditional invasive electrical methods include non-invasiveness, full-brain "reading and writing," and multi-target neural circuit regulation, addressing a wide range of clinical needs [5][6]. Product Development and Clinical Trials - Gestala Technology plans to establish its headquarters and first production line in Chengdu by the second quarter of this year, with the first product focusing on chronic pain management [6]. - Clinical trials have shown that a single stimulation can reduce pain scale scores by 50%, with effects lasting 1-2 weeks [6]. Strategic Vision - The company aims to create a brain-machine interface platform based on ultrasound with full-brain reading and writing capabilities, providing innovative treatment methods for various neurological diseases and exploring the integration of brain science and artificial intelligence [6][7].